Learn
Delve into dermatology diseases with new approaches from conventional to complementary care.
Topics
Explore a broad spectrum of dermatological conditions and topics to enhance your practice.
Training Programs
Expert led instruction for every level of patient care.
Log in to see enrolled program content.
Conferences
Gain practical insights and meet new colleagues.
Hover over a conference to view recordings.
Join Us
The largest integrative dermatology community.
The Emergence of JAK/TEC Inhibitors and IL-17/23 Biologics
Course Overview
Preview what you'll learn in this program
What You'll Learn
This session will serve as a global discussion of emerging IL-17/23 inhibiting biologics and JAK and TEC inhibitors and how they would be utilized in clinical practice. The discussion will include evidence around safety when utilizing JAK/TEC inhibitors and will draw from the existing literature.
Faculty
Editors
Accreditation Information
This session will serve as a global discussion of emerging IL-17/23 inhibiting biologics and JAK and TEC inhibitors and how they would be utilized in clinical practice. The discussion will include evidence around safety when utilizing JAK/TEC inhibitors and will draw from the existing literature.
✨ Ready to Begin Your Journey? ✨
Enroll now to start the course and unlock all learning materials
The Emergence of JAK/TEC Inhibitors and IL-17/23 Biologics
Complete the previous section to unlock this lesson
Course Discussion
Join the conversation with fellow learners
Also Recommended
Hidradenitis Suppurativa: Case Based Management
Managing Pain in a Patient with Hidradenitis Suppurativa
Clinical Approach to Hidradenitis Suppurativa and Emerging Therapies
Understanding Aspects of Shared Decision Making in a Patient with Hidradenitis Suppurativa
